Across TCGA pan-cancer cohorts, SSB RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated SSB data layer compared with 5 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher SSB RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SSB expression acts as an unfavorable survival marker, although some lineages such as KIRC and THCA show a favorable association.
KIRP, ACC, and LIHC are the cancer types where SSB RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.